Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

ClinicalTrials.gov ID: NCT03510897

Public ClinicalTrials.gov record NCT03510897. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 12:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for Acute Kidney Injury (AKI) Following Cardiac Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is designed to evaluate QPI-1002 versus placebo for the prevention of Major Adverse Kidney Events (MAKE) in subjects at high risk for acute kidney injury following cardiac surgery. Half of the participants will receive QPI-1002 while the other half will receive placebo.

Study identification

NCT ID
NCT03510897
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Quark Pharmaceuticals
Industry
Enrollment
1,043 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 28, 2018
Primary completion
Oct 13, 2020
Completion
Apr 11, 2021
Last update posted
Jul 15, 2021

2018 – 2021

United States locations

U.S. sites
36
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Hospital Birmingham Alabama 35294
Keck Hospital of USC Los Angeles California 90033
Cedar-Sinai Heart Institute Los Angeles California 90048
Ronald Regan UCLA Medical Center Los Angeles California 90095
Yale University School of Medicine New Haven Connecticut 06510
River City Clinical Research Jacksonville Florida 32207
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Emory Saint Joseph's Hospital Atlanta Georgia 30342
Northwestern University Evanston Illinois 60208
Indiana/ Ohio Heart, a division of Luthern Medical Group, LLC Fort Wayne Indiana 46804
Indiana University Health-Methodist Hospital Indianapolis Indiana 46202
University of Kentucky Healthcare Lexington Kentucky 40536
University of Louisville Physicians (ULP) Louisville Kentucky 40202
Massachusetts General Hospital Boston Massachusetts 02114
MidMichigan Medical Center Midland Midland Michigan 48670
Cardiac & Vascular Research Center of Northern Michigan Petoskey Michigan 49770
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111
Bryan Heart Lincoln Nebraska 68506
Nebraska Heart Hospital Lincoln Nebraska 68526
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Saint Barnabas Medical Center Livingston New Jersey 07039
Columbia University Medical Center New York New York 10032
Mission Hospital, Inc. Asheville North Carolina 28801
Duke University Hospital Medical Center Durham North Carolina 27710
East Carolina Heart Institute at East Carolina University Greenville North Carolina 27834
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Oregon Health and Science University Portland Oregon 97239
Medical University of South Carolina Charleston South Carolina 29425
Baylor Jack and Jane Hamilton Heart and Vascular Hospital - Soltero Cardiovasular Dallas Texas 75246
University of Texas Southwestern Medical Center Dallas Texas 75390
University of Utah Health Salt Lake City Utah 84132
University of Virginia Charlottesville Virginia 22908
Virginia Commonwealth University Medical Center Richmond Virginia 23298
University Hospital Madison Wisconsin 53792
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03510897, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03510897 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →